Annual EBITDA
-$143.16 M
-$37.91 M-36.01%
31 December 2023
Summary:
AnaptysBio annual earnings before interest, taxes, depreciation & amortization is currently -$143.16 million, with the most recent change of -$37.91 million (-36.01%) on 31 December 2023. During the last 3 years, it has fallen by -$88.91 million (-163.87%). ANAB annual EBITDA is now -2895.63% below its all-time high of $5.12 million, reached on 31 December 2014.ANAB EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$16.84 M
+$18.26 M+52.02%
01 September 2024
Summary:
AnaptysBio quarterly earnings before interest, taxes, depreciation & amortization is currently -$16.84 million, with the most recent change of +$18.26 million (+52.02%) on 01 September 2024. Over the past year, it has increased by +$19.81 million (+54.05%). ANAB quarterly EBITDA is now -144.42% below its all-time high of $37.92 million, reached on 31 December 2020.ANAB Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$125.61 M
+$15.44 M+10.95%
01 September 2024
Summary:
AnaptysBio TTM earnings before interest, taxes, depreciation & amortization is currently -$125.61 million, with the most recent change of +$15.44 million (+10.95%) on 01 September 2024. Over the past year, it has increased by +$17.55 million (+12.26%). ANAB TTM EBITDA is now -974.55% below its all-time high of $14.36 million, reached on 30 September 2021.ANAB TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANAB EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +54.0% | +12.3% |
| 3 y3 years | -163.9% | +45.1% | -131.5% |
| 5 y5 years | -50.6% | +11.6% | -32.2% |
ANAB EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -163.9% | at low | at high | +57.2% | -131.5% | +12.3% |
| 5 y | 5 years | -681.7% | at low | -144.4% | +57.2% | -974.5% | +12.3% |
| alltime | all time | -2895.6% | at low | -144.4% | +57.2% | -974.5% | +12.3% |
AnaptysBio EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$16.84 M(-52.0%) | -$125.61 M(-10.9%) |
| June 2024 | - | -$35.10 M(-5.2%) | -$141.06 M(+0.1%) |
| Mar 2024 | - | -$37.01 M(+1.0%) | -$140.85 M(-1.6%) |
| Dec 2023 | -$143.16 M(+36.0%) | -$36.65 M(+13.5%) | -$143.16 M(+11.8%) |
| Sept 2023 | - | -$32.28 M(-7.5%) | -$128.04 M(+4.5%) |
| June 2023 | - | -$34.90 M(-11.3%) | -$122.54 M(+7.7%) |
| Mar 2023 | - | -$39.33 M(+82.6%) | -$113.75 M(+8.1%) |
| Dec 2022 | -$105.26 M(+94.0%) | -$21.53 M(-19.6%) | -$105.26 M(-8.0%) |
| Sept 2022 | - | -$26.78 M(+2.6%) | -$114.43 M(+22.2%) |
| June 2022 | - | -$26.11 M(-15.3%) | -$93.64 M(+39.4%) |
| Mar 2022 | - | -$30.83 M(+0.4%) | -$67.17 M(+23.8%) |
| Dec 2021 | -$54.26 M(+196.3%) | -$30.70 M(+412.0%) | -$54.26 M(-477.7%) |
| Sept 2021 | - | -$6.00 M(-1784.6%) | $14.36 M(-494.5%) |
| June 2021 | - | $356.00 K(-102.0%) | -$3.64 M(-86.1%) |
| Mar 2021 | - | -$17.91 M(-147.2%) | -$26.11 M(+42.6%) |
| Dec 2020 | -$18.31 M(-80.7%) | $37.92 M(-258.0%) | -$18.31 M(-75.7%) |
| Sept 2020 | - | -$24.00 M(+8.5%) | -$75.28 M(-8.2%) |
| June 2020 | - | -$22.12 M(+118.7%) | -$81.99 M(-1.8%) |
| Mar 2020 | - | -$10.11 M(-46.9%) | -$83.49 M(-12.2%) |
| Dec 2019 | -$95.04 M | -$19.05 M(-38.0%) | -$95.04 M(+2.5%) |
| Sept 2019 | - | -$30.71 M(+30.0%) | -$92.70 M(+19.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2019 | - | -$23.62 M(+9.0%) | -$77.46 M(+15.7%) |
| Mar 2019 | - | -$21.66 M(+29.6%) | -$66.96 M(+11.8%) |
| Dec 2018 | -$59.88 M(+113.0%) | -$16.71 M(+8.1%) | -$59.88 M(+20.9%) |
| Sept 2018 | - | -$15.47 M(+17.9%) | -$49.52 M(+16.1%) |
| June 2018 | - | -$13.12 M(-10.0%) | -$42.65 M(+34.4%) |
| Mar 2018 | - | -$14.58 M(+129.3%) | -$31.73 M(+12.9%) |
| Dec 2017 | -$28.11 M(+687.9%) | -$6.36 M(-26.0%) | -$28.11 M(+7.4%) |
| Sept 2017 | - | -$8.59 M(+291.6%) | -$26.16 M(+41.3%) |
| June 2017 | - | -$2.19 M(-80.0%) | -$18.51 M(+34.0%) |
| Mar 2017 | - | -$10.97 M(+148.8%) | -$13.82 M(+287.3%) |
| Dec 2016 | -$3.57 M(-21.3%) | -$4.41 M(+368.5%) | -$3.57 M(+48.2%) |
| Sept 2016 | - | -$941.00 K(-137.7%) | -$2.41 M(-10.7%) |
| June 2016 | - | $2.50 M(-448.9%) | -$2.69 M(-46.8%) |
| Mar 2016 | - | -$716.00 K(-78.0%) | -$5.06 M(+11.7%) |
| Dec 2015 | -$4.53 M(-188.5%) | -$3.25 M(+164.5%) | -$4.53 M(+550.2%) |
| Sept 2015 | - | -$1.23 M(-1030.3%) | -$697.00 K(-117.1%) |
| June 2015 | - | $132.00 K(-170.2%) | $4.07 M(+3.4%) |
| Mar 2015 | - | -$188.00 K(-132.0%) | $3.94 M(-4.6%) |
| Dec 2014 | $5.12 M(-225.5%) | $587.00 K(-83.4%) | $4.12 M(+16.6%) |
| Sept 2014 | - | $3.54 M | $3.54 M |
| Dec 2013 | -$4.08 M | - | - |
FAQ
- What is AnaptysBio annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for AnaptysBio?
- What is AnaptysBio quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for AnaptysBio?
- What is AnaptysBio quarterly EBITDA year-on-year change?
- What is AnaptysBio TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for AnaptysBio?
- What is AnaptysBio TTM EBITDA year-on-year change?
What is AnaptysBio annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of ANAB is -$143.16 M
What is the all time high annual EBITDA for AnaptysBio?
AnaptysBio all-time high annual earnings before interest, taxes, depreciation & amortization is $5.12 M
What is AnaptysBio quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of ANAB is -$16.84 M
What is the all time high quarterly EBITDA for AnaptysBio?
AnaptysBio all-time high quarterly earnings before interest, taxes, depreciation & amortization is $37.92 M
What is AnaptysBio quarterly EBITDA year-on-year change?
Over the past year, ANAB quarterly earnings before interest, taxes, depreciation & amortization has changed by +$19.81 M (+54.05%)
What is AnaptysBio TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of ANAB is -$125.61 M
What is the all time high TTM EBITDA for AnaptysBio?
AnaptysBio all-time high TTM earnings before interest, taxes, depreciation & amortization is $14.36 M
What is AnaptysBio TTM EBITDA year-on-year change?
Over the past year, ANAB TTM earnings before interest, taxes, depreciation & amortization has changed by +$17.55 M (+12.26%)